A night after Carlos Alcaraz fell in the second round, the 24-time Grand Slam champion was taken out in the third.
Sumitomo Pharma America, Inc. (SMPA) today presented new clinical data supporting further development of enzomenib, an investigational, oral selective menin inhibitor being researched for the ...
Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-314 clinical trial evaluating Jaypirca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback